ResMed Inc (BSP:R1MD34)
R$ 381 9.84 (2.65%) Market Cap: 223.72 Bil Enterprise Value: 226.25 Bil PE Ratio: 32.98 PB Ratio: 7.04 GF Score: 86/100

Q2 2021 Resmed Inc Earnings Call Transcript

Jan 28, 2021 / 09:30PM GMT
Release Date Price: R$289.29
Operator

Welcome to the Q2 Fiscal Year 2021 ResMed Earnings Conference Call. My name is Chantel, and I'll be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded.

I will now turn the call over to Amy Wakeham, Vice President, Investor Relations and Corporate Communications. Amy, you may begin.

Amy Wakeham
ResMed Inc. - VP of IR & Corporate Communications

Great. Thank you, Chantel. Good morning, and good afternoon, everyone. Welcome to ResMed's Second Quarter Fiscal Year 2021 Earnings Conference Call. Thanks for joining us. This call is being webcast live and the replay, along with a copy of the earnings press release and our updated investor presentation, will be available on the Investor Relations section of our corporate website later today.

With me on the call today are our CEO, Mick Farrell; and CFO, Brett Sandercock; and several other members of management will be available during the Q&A following our prepared remarks.

During today's call, we will discuss some non-GAAP

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot